Patent · US Active

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

US9474728B2 · kind B2 · utility

15Cited by
50References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2014
Grant dateOct 25, 2016
Priority date
Expiry dateSep 5, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2866
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for the treatment or prevention of fatigue associated with disordered sleep, for example, in multiple sclerosis, fibromyalgia, Fabry's disease, Parkinson's disease, or traumatic brain injury, using cyclobenzaprine. The present invention further relates to a biomarker for the therapeutic effects of a cyclobenzaprine treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.